Graded Motor Imagery and Total Knee Arthroplasty
Launched by INONU UNIVERSITY · Nov 17, 2021
Trial Information
Current as of June 30, 2025
Unknown status
Keywords
ClinConnect Summary
Participants aged 45-80 who are scheduled for total knee arthroplasty surgery after knee osteoarthritis will be included. Participants will be selected from the relevant population using a nonprobability random sampling method. Participants who agree to participate in the study and meet the inclusion criteria will be assigned to one of the groups (conventional rehabilitation-only or conventional rehabilitation with graded motor imagery) using the closed envelope method. Evaluations will be made one day before surgery, 6 weeks and 6 months after surgery for each group. Pain Visual Analog Sca...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with knee osteoarthritis and being on the waiting list to receive unilateral total knee arthroplasty
- • Approved by the orthopedist for early physiotherapy treatment after total knee arthroplasty
- Exclusion Criteria:
- • - Individuals undergoing revision total knee arthroplasty or undergoing bilateral total knee arthroplasty,
- • Contralateral knee osteoarthritis (defined by activity greater than 4/10 pain)
- • Having undergone any physical therapy intervention or other surgery in the last 6 months
- • Any neurological, cardiac, pulmonary or psychiatric disease (eg, uncontrolled diabetes mellitus, neoplasms, uncontrolled blood pressure, neurological conditions) before or after surgery;
- • Fracture, infection in the acute postoperative phase or presence of fever
- • Cognitive impairments that alter the probability of correct understanding of the motor imagery program
- • Body mass index \> 35 kg / m2
- • Difficulties with understanding or communication
- • Insufficient knowledge of Turkish to follow the study instructions.
About Inonu University
Inonu University is a prominent academic institution located in Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative research initiatives aimed at improving patient care and advancing scientific knowledge. With a strong commitment to ethical standards and regulatory compliance, Inonu University collaborates with various stakeholders, including healthcare professionals and industry partners, to conduct rigorous clinical trials that contribute to the development of new therapies and treatment modalities. Through its research endeavors, the university strives to enhance healthcare outcomes and foster a culture of inquiry within the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Malatya, , Turkey
Patients applied
Trial Officials
Burcu TALU
Principal Investigator
Inonu University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials